Acurx Pharmaceuticals, Inc. (ACXP) — 分析师展望 / 分析师共识目标价为. 基于 3 位分析师评级, 共识为 看涨 — 3 买入.
分析师预估 每股收益(EPS)为 $-16.80 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-872.54 vs 预期 $-16.80 (不及预期 -5093.7%). 2025: 实际 $-5.32 vs 预期 $-6.05 (超预期 +12%). 分析师准确度: 44%.
ACXP 分析师评级
Buy
基于过去3个月内 3 位分析师对 Acurx Pharmaceuticals, Inc. 的评级
EPS 预测 — ACXP
44%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$872.54
vs Est –$16.80
▼ 98.1% off
2025
Actual –$5.32
vs Est –$6.05
▲ 13.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — ACXP
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
